Company Profile
Boditech Med offers instruments and diagnostic reagents in South Korea and globally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases.
Its portfolio also includes ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters, ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges, ichroma-50, an automated immunoassay system with high-throughput, Hemochroma PLUS, a handheld device that can run tests for anemia, portable analyzers ichroma M3 and ichroma M2, and NuActor, an automated nucleic acid extraction system, as well as compact immunoassay analyzers, including AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10.
Its portfolio also includes cardiac reagents, cancer reagents, COVID-19 reagents, diagnostic reagents, and reagents for hormones, infections, autoimmune, organ functions, molecular diagnostics, therapeutic drug monitoring, and test items.
Additionally, it offers Ichroma TRIAS, ultra-high sensitivity respiratory disease diagnostic equipment. Its portfolio also includes ALFIAS-3, a diagnostic equipment, and SyncNeb. Founded in 1998, Boditech Med is headquartered in Chuncheon-si, South Korea.